Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- PPalliative care items
- MPMedical Practitioner
- MWMidwife
- NPNurse Practitioner
-
SO
Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 9357L | IBANDRONATEibandronate 50 mg tablet, 28 | 1 | 28 | 2 |
MPNP | 3190X | IBUPROFENibuprofen 400 mg tablet, 30 | 3 | 90 | 3 |
MPMWNP | 3192B | IBUPROFENibuprofen 400 mg tablet, 30 | 1 | 30 | 0 |
MPNP | 5368M | IBUPROFENibuprofen 400 mg tablet, 30 | 3 | 90 | 3 |
MPNP | 2420J | IMIPRAMINEimipramine hydrochloride 10 mg tablet, 50 | 1 | 50 | 2 |
MPNP | 2421K | IMIPRAMINEimipramine hydrochloride 25 mg tablet, 50 | 1 | 50 | 2 |
MPNP | 12113M | IMIPRAMINEimipramine hydrochloride 25 mg tablet, 100 | 0.5 | 50 | 2 |
MPNP | 5134F | INDACATEROLindacaterol 150 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 5137J | INDACATEROLindacaterol 300 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 10156M | INDACATEROL + GLYCOPYRRONIUMindacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 12295D | INDACATEROL + GLYCOPYRRONIUM + MOMETASONEindacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 12298G | INDACATEROL + GLYCOPYRRONIUM + MOMETASONEindacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 68 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 12269R | INDACATEROL + MOMETASONEindacaterol 125 microgram + mometasone furoate 62.5 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 12279G | INDACATEROL + MOMETASONEindacaterol 125 microgram + mometasone furoate 260 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 12289T | INDACATEROL + MOMETASONEindacaterol 125 microgram + mometasone furoate 127.5 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 13475F | INDAPAMIDEindapamide hemihydrate 1.5 mg modified release tablet, 90 | 2 | 180 | 1 |
MPNP | 8532C | INDAPAMIDEindapamide hemihydrate 1.5 mg modified release tablet, 90 | 1 | 90 | 1 |
MPNP | 13378D | INDAPAMIDEindapamide hemihydrate 2.5 mg tablet, 90 | 2 | 180 | 1 |
MPNP | 2436F | INDAPAMIDEindapamide hemihydrate 2.5 mg tablet, 90 | 1 | 90 | 1 |
MPNP | 2454E | INDOMETACINindometacin 25 mg capsule, 50 | 2 | 100 | 3 |
MPNP | 5377B | INDOMETACINindometacin 25 mg capsule, 50 | 2 | 100 | 3 |
MPNP | 2757D | INDOMETACINindometacin 100 mg suppository, 20 | 2 | 40 | 3 |
MPNP | 12254Y | INSULIN ASPARTinsulin aspart 100 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 8571D | INSULIN ASPARTinsulin aspart 100 units/mL injection, 1 x 10 mL vial | 5 | 5 | 2 |
MPNP | 8435Y | INSULIN ASPARTinsulin aspart 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 13651L | INSULIN ASPARTinsulin aspart 100 units/mL fast acting injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 8609D | INSULIN ASPART + INSULIN ASPART PROTAMINEinsulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 12238D | INSULIN ASPART + INSULIN ASPART PROTAMINEinsulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 11417X | INSULIN DEGLUDEC + INSULIN ASPARTinsulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 11426J | INSULIN DEGLUDEC + INSULIN ASPARTinsulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 12236B | INSULIN DETEMIRinsulin detemir 100 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 9040T | INSULIN DETEMIRinsulin detemir 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 9039R | INSULIN GLARGINEinsulin glargine 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 11815W | INSULIN GLARGINEinsulin glargine 100 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 11308E | INSULIN GLARGINEinsulin glargine 300 units/mL injection, 3 x 1.5 mL pen devices | 5 | 5 | 1 |
MPNP | 11302W | INSULIN GLARGINEinsulin glargine 300 units/mL injection, 5 x 1.5 mL pen devices | 5 | 5 | 1 |
MPNP | 12268Q | INSULIN GLULISINEinsulin glulisine 100 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 9224L | INSULIN GLULISINEinsulin glulisine 100 units/mL injection, 1 x 10 mL vial | 5 | 5 | 2 |
MPNP | 1921D | INSULIN GLULISINEinsulin glulisine 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 1533Q | INSULIN ISOPHANE HUMANinsulin isophane human 100 units/mL injection, 1 x 10 mL vial | 5 | 5 | 2 |
MPNP | 1761Q | INSULIN ISOPHANE HUMANinsulin isophane human 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 12262J | INSULIN ISOPHANE HUMANinsulin isophane human 100 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 8084L | INSULIN LISPROinsulin lispro 100 units/mL injection, 1 x 10 mL vial | 5 | 5 | 2 |
MPNP | 8212F | INSULIN LISPROinsulin lispro 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 11645X | INSULIN LISPROinsulin lispro 200 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 12237C | INSULIN LISPROinsulin lispro 100 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 8390N | INSULIN LISPRO + INSULIN LISPRO PROTAMINEinsulin lispro 25 units/mL + insulin lispro protamine 75 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 12234X | INSULIN LISPRO + INSULIN LISPRO PROTAMINEinsulin lispro 25 units/mL + insulin lispro protamine 75 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 8874C | INSULIN LISPRO + INSULIN LISPRO PROTAMINEinsulin lispro 50 units/mL + insulin lispro protamine 50 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 12261H | INSULIN LISPRO + INSULIN LISPRO PROTAMINEinsulin lispro 50 units/mL + insulin lispro protamine 50 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 1531N | INSULIN NEUTRAL HUMANinsulin neutral human 100 units/mL injection, 1 x 10 mL vial | 5 | 5 | 2 |
MPNP | 1762R | INSULIN NEUTRAL HUMANinsulin neutral human 100 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 2062M | INSULIN NEUTRAL HUMAN + INSULIN ISOPHANE HUMANinsulin neutral human 50 units/mL + insulin isophane human 50 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 12255B | INSULIN NEUTRAL HUMAN + INSULIN ISOPHANE HUMANinsulin neutral human 30 units/mL + insulin isophane human 70 units/mL injection, 5 x 3 mL pen devices | 5 | 5 | 1 |
MPNP | 1426C | INSULIN NEUTRAL HUMAN + INSULIN ISOPHANE HUMANinsulin neutral human 30 units/mL + insulin isophane human 70 units/mL injection, 10 mL vial | 5 | 5 | 2 |
MPNP | 1763T | INSULIN NEUTRAL HUMAN + INSULIN ISOPHANE HUMANinsulin neutral human 30 units/mL + insulin isophane human 70 units/mL injection, 5 x 3 mL cartridges | 5 | 5 | 1 |
MPNP | 8671J | IPRATROPIUMipratropium bromide monohydrate 21 microgram/actuation inhalation, 200 actuations | 2 | 2 | 5 |
MPNP | 1542E | IPRATROPIUMipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules | 2 | 2 | 5 |
MPNP | 8238N | IPRATROPIUMipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules | 2 | 2 | 5 |
MPNP | 13380F | IRBESARTANirbesartan 150 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8247C | IRBESARTANirbesartan 150 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13564X | IRBESARTANirbesartan 300 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8248D | IRBESARTANirbesartan 300 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13435D | IRBESARTANirbesartan 75 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8246B | IRBESARTANirbesartan 75 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13572H | IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8404H | IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13545X | IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8405J | IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13446Q | IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 2136K | IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 2593L | IRON POLYMALTOSEiron (as polymaltose) 100 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 0 |
MPNP | 2805P | IRON POLYMALTOSEiron (as polymaltose) 100 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 5 |
MPNP | 10229J | IRON SUCROSEiron (as sucrose) 100 mg/5 mL injection, 5 x 5 mL ampoules | 1 | 5 | 0 |
MPNP | 8807M | IRON SUCROSEiron (as sucrose) 100 mg/5 mL injection, 5 x 5 mL ampoules | 1 | 5 | 5 |
MPNP | 9436P | ISOLEUCINE WITH CARBOHYDRATEisoleucine with carbohydrate containing 1 g isoleucine powder for oral liquid, 30 x 4 g sachets | 4 | 4 | 5 |
MPNP | 9134R | ISOLEUCINE WITH CARBOHYDRATEisoleucine with carbohydrate containing 50 mg isoleucine powder for oral liquid, 30 x 4 g sachets | 4 | 4 | 5 |
MPNP | 1554T | ISONIAZIDisoniazid 100 mg tablet, 100 | 1 | 100 | 2 |
MPNP | 13491C | ISOSORBIDE DINITRATEisosorbide dinitrate 5 mg sublingual tablet, 100 | 4 | 400 | 2 |
MPNP | 2588F | ISOSORBIDE DINITRATEisosorbide dinitrate 5 mg sublingual tablet, 100 | 2 | 200 | 2 |
MPNP | 8273K | ISOSORBIDE MONONITRATEisosorbide mononitrate 120 mg modified release tablet, 30 | 1 | 30 | 5 |
MPNP | 13611J | ISOSORBIDE MONONITRATEisosorbide mononitrate 120 mg modified release tablet, 30 | 2 | 60 | 5 |
MPNP | 13461L | ISOSORBIDE MONONITRATEisosorbide mononitrate 60 mg modified release tablet, 30 | 2 | 60 | 5 |
MPNP | 1558B | ISOSORBIDE MONONITRATEisosorbide mononitrate 60 mg modified release tablet, 30 | 1 | 30 | 5 |
MPNP | 10732W | ITRACONAZOLEitraconazole 50 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 8196J | ITRACONAZOLEitraconazole 100 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 10012Y | IVABRADINEivabradine 5 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 2960T | IVABRADINEivabradine 7.5 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 2868Y | IVERMECTINivermectin 3 mg tablet, 4 | 2 | 8 | 2 |
MPNP | 8359Y | IVERMECTINivermectin 3 mg tablet, 4 | 1 | 4 | 0 |